Mark A. Gardner
CIK: 0001955242
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About GARDNER MARK A
GARDNER MARK A (SEC CIK 0001955242) files insider reports with the SEC as President of GeneDx Holdings Corp. (WGS) and SVP of Molecular Gen & Oncol of QUEST DIAGNOSTICS INC (DGX).
Signal8 holds 3 ownership filings by GARDNER MARK A (1 Form 3, 2 Form 4), filed between Sep 26, 2024 and Jul 1, 2026. Those filings report 2 transactions, from Sep 24, 2024 to Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GARDNER MARK A's filings is in STAMFORD, CT.
Recent filings by GARDNER MARK A
Other insiders filing for GeneDx Holdings Corp. (WGS)
- Stueland Katherine, CHIEF EXECUTIVE OFFICER
- Feeley Kevin, CHIEF FINANCIAL OFFICER
- Fuchs Thomas, Director
- Ryan Jason, Director
- RUCH JOSHUA, Director
- PFENNIGER RICHARD C JR, Director